Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors.
about
Histone/protein deacetylase inhibitor therapy for enhancement of Foxp3+ T-regulatory cell function posttransplantation.Epigenetic modifications in KDM lysine demethylases associate with survival of early-stage NSCLC.Lysine-14 acetylation of histone H3 in chromatin confers resistance to the deacetylase and demethylase activities of an epigenetic silencing complex.Histone deacetylase (HDAC) 1 and 2 complexes regulate both histone acetylation and crotonylation in vivoPharmacological inhibition of LSD1 activity blocks REST-dependent medulloblastoma cell migrationSonoporation by microbubbles as gene therapy approach against liver cancer
P2860
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors.
@en
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors.
@nl
type
label
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors.
@en
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors.
@nl
prefLabel
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors.
@en
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors.
@nl
P2093
P2860
P50
P1476
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors.
@en
P2093
Andrea V Gomez
Antonello Mai
Charles Milano
Charlotte M Proby
Dawn Hayward
Edward Kim
Holly J Roberts
Izabela Panova
Jayanta Das
Michelle A Rudek
P2860
P2888
P356
10.1038/S41467-017-02242-4
P407
P50
P577
2018-01-04T00:00:00Z